Related Experiment Videos
Pregnancy and cystic fibrosis: a case-controlled study
D D Frangolias1, E M Nakielna, P G Wilcox
1Pulmonary Research Laboratories, University of British Columbia, Vancouver, Canada.
Chest
|April 1, 1997
Summary
Pregnancy generally has minimal adverse effects on women with stable cystic fibrosis (CF). However, individuals with advanced CF may experience poorer outcomes, highlighting the importance of pre-pregnancy health status.
Area of Science:
- Cardiorespiratory Health
- Reproductive Health in Chronic Illness
Background:
- Pregnancy imposes significant physiological demands, potentially exacerbating morbidity in women with cystic fibrosis (CF).
- Pre-pregnancy health status is a critical determinant of pregnancy outcomes and long-term maternal survival in CF patients.
Purpose of the Study:
- To evaluate the impact of pregnancy on the clinical course of women with cystic fibrosis (CF).
- To assess the relationship between pre-pregnancy status and 2-year post-pregnancy survival in CF patients.
Main Methods:
- Matched cohort study comparing pregnant CF patients with non-pregnant controls.
- Data collected included pulmonary function (FEV1, FVC), weight, clinical scores (S-K, Brasfield), and exacerbations from 1 year preconception to 2 years postpartum.
Main Results:
- No significant difference in pulmonary function decline between pregnant and non-pregnant CF groups.
- Pregnant CF patients showed greater decline in body weight and Brasfield scores postpartum.
- One pregnancy-associated death occurred 6 months postpartum in a patient with advanced disease.
Conclusions:
- Pregnancy poses minimal risk to women with stable cystic fibrosis.
- Women with advanced CF disease face higher risks during pregnancy and postpartum.
- Individualized risk assessment and management are crucial for pregnant CF patients.